| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| L Cinnamon Bidwell, Hollis C Karoly, Marco Ortiz Torres, Ashley Master, Angela D Bryan, Kent E Hutchiso. A naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. Psychopharmacology. 2021-10-28. PMID:34708254. |
a naturalistic study of orally administered vs. inhaled legal market cannabis: cannabinoids exposure, intoxication, and impairment. |
2021-10-28 |
2023-08-13 |
Not clear |
| Pratibha Malhotra, Ilaria Casari, Marco Falasc. Therapeutic potential of cannabinoids in combination cancer therapy. Advances in biological regulation. vol 79. 2021-10-27. PMID:33422460. |
the word cannabinoid is a term describing chemical compounds that are either derivate of cannabis (phytocannabinoids) or artificial analogues (synthetic) or are produced endogenously by the body (endocannabinoids). |
2021-10-27 |
2023-08-13 |
Not clear |
| Aaron J Pandopulos, Bradley S Simpson, Richard Bade, Jake W O'Brien, Meena K Yadav, Jason M White, Cobus Gerbe. A method and its application to determine the amount of cannabinoids in sewage sludge and biosolids. Environmental science and pollution research international. vol 28. issue 42. 2021-10-27. PMID:34143389. |
in this study, a liquid-liquid extraction method was developed for the extraction and detection method for 50 cannabinoids by liquid chromatography-mass spectrometry, including the cannabis urinary biomarker 11-nor-9-carboxy-Δ |
2021-10-27 |
2023-08-13 |
Not clear |
| Jiexin Cao, Stuart C Mange. Interactions of cone cannabinoid CB1 and dopamine D4 receptors increase day/night difference in rod-cone gap junction coupling in goldfish retina. The Journal of physiology. vol 599. issue 17. 2021-10-27. PMID:34252195. |
although cone and rod photoreceptor cells in the retina have a type of cannabinoid receptor called a cb1 receptor, little is known about how cannabinoids, the active component in marijuana, affect retinal function. |
2021-10-27 |
2023-08-13 |
Not clear |
| Tom P Freeman, Valentina Lorenzett. A standard THC unit for reporting of health research on cannabis and cannabinoids. The lancet. Psychiatry. vol 8. issue 11. 2021-10-27. PMID:34506750. |
a standard thc unit for reporting of health research on cannabis and cannabinoids. |
2021-10-27 |
2023-08-13 |
Not clear |
| Udo Bonnet, Thorsten Borda, Norbert Scherbaum, Michael Speck. Long-Term Frequent Cannabis Use and Related Serum Cannabinoid Levels Are Not Associated with Kidney Dysfunction. Cannabis and cannabinoid research. 2021-10-27. PMID:34704814. |
long-term frequent cannabis use and related serum cannabinoid levels are not associated with kidney dysfunction. |
2021-10-27 |
2023-08-13 |
Not clear |
| Benthe H Doeve, Maartje M van de Meeberg, Fiona D M van Schaik, Herma H Fidde. A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies? Journal of clinical gastroenterology. vol 55. issue 9. 2021-10-26. PMID:32675631. |
a systematic review with meta-analysis of the efficacy of cannabis and cannabinoids for inflammatory bowel disease: what can we learn from randomized and nonrandomized studies? |
2021-10-26 |
2023-08-13 |
Not clear |
| Benthe H Doeve, Maartje M van de Meeberg, Fiona D M van Schaik, Herma H Fidde. A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies? Journal of clinical gastroenterology. vol 55. issue 9. 2021-10-26. PMID:32675631. |
a number of studies have investigated the effectiveness of cannabis or cannabinoids for treatment of inflammatory bowel diseases (ibd). |
2021-10-26 |
2023-08-13 |
Not clear |
| Katie Pizzolato, David Thacker, Nicole Del Toro-Pagán, Abeer Hanna, Jacques Turgeon, Adriana Matos, Nishita Amin, Veronique Michau. Cannabis Dopaminergic Effects Induce Hallucinations in a Patient with Parkinson's Disease. Medicina (Kaunas, Lithuania). vol 57. issue 10. 2021-10-26. PMID:34684144. |
cannabis products that contain the tetrahydrocannabinol (thc) cannabinoid are emerging as promising therapeutic agents for the treatment of medical conditions such as chronic pain. |
2021-10-26 |
2023-08-13 |
Not clear |
| Irene Braithwaite, Chiranth Bhagavan, Marjan Doppen, Stacey Kung, Karen Oldfield, Giles Newton-Howe. Medicinal applications of cannabis/cannabinoids. Current opinion in psychology. vol 38. 2021-10-25. PMID:32652488. |
regulatory approvals for epidiolex (purified cannabidiol) in the treatment of childhood drug resistant epilepsy have set a precedent for the use of cannabinoids as a prescribed medicine. |
2021-10-25 |
2023-08-13 |
Not clear |
| Jonas Carneiro Cruz, Luís Felippe Cabral Miranda, Maria Eugênia Costa Queiro. Pipette tip micro-solid phase extraction (octyl-functionalized hybrid silica monolith) and ultra-high-performance liquid chromatography-tandem mass spectrometry to determine cannabidiol and tetrahydrocannabinol in plasma samples. Journal of separation science. vol 44. issue 8. 2021-10-25. PMID:33387419. |
this manuscript describes the development of an innovative method to determine cannabinoids (cannabidiol and tetrahydrocannabinol) in human plasma samples by pipette tip micro-solid phase extraction and liquid chromatography-mass spectrometry/mass spectromtery. |
2021-10-25 |
2023-08-13 |
human |
| Alexander N Melinyshyn, Farnaz Amoozega. Cannabinoid Use in a Tertiary Headache Clinic: A Cross-Sectional Survey. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques. 2021-10-25. PMID:34511153. |
this study seeks to determine the prevalence and nature of cannabis use in patients with headache in a tertiary headache clinic and to explore patients' empiric experience in using cannabinoids therapeutically. |
2021-10-25 |
2023-08-13 |
Not clear |
| Giuliano Boscutti, Vittorio Di Maso, Alessandra Marega, Ugo Gerini, Alberto Zacchi, Francesco Bianc. [Droghe d'abuso e rene]. Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. vol 38. issue Suppl 77. 2021-10-25. PMID:34669304. |
this give us the opportunity to review the renal effects of the main drugs of abuse, highlighting the shift occured from the four "old sisters" (marijuana, cocaine, heroin and amphetamine) to the news synthetic drugs (chiefly synthetic cathinones and cannabinoids), that poses problems due to large diffusion, easy procurement, legal non-regulation and difficult analytical identification, raising medical and forensic questions. |
2021-10-25 |
2023-08-13 |
Not clear |
| Gianmaria Magagnini, Gianpaolo Grassi, Stiina Kotirant. The Effect of Light Spectrum on the Morphology and Cannabinoid Content of Cannabis sativa L. Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676318. |
the effect of light spectrum on the morphology and cannabinoid content of cannabis sativa l. |
2021-10-23 |
2023-08-13 |
Not clear |
| Magdalena Grill, Carina Hasenoehrl, Martin Storr, Rudolf Schich. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676319. |
medical cannabis and cannabinoids: an option for the treatment of inflammatory bowel disease and cancer of the colon? |
2021-10-23 |
2023-08-13 |
human |
| Jürg Gertsc. The Intricate Influence of the Placebo Effect on Medical Cannabis and Cannabinoids. Medical cannabis and cannabinoids. vol 1. issue 1. 2021-10-23. PMID:34676323. |
the intricate influence of the placebo effect on medical cannabis and cannabinoids. |
2021-10-23 |
2023-08-13 |
Not clear |
| Joseph V Pergolizzi, Jo Ann LeQuang, John F Bisne. Cannabinoid Hyperemesis. Medical cannabis and cannabinoids. vol 1. issue 2. 2021-10-23. PMID:34676325. |
cannabinoid hyperemesis syndrome (chs) is a paradoxical condition in which a long-term cannabis user suffers an episode of intractable vomiting that may last days separated by longer asymptomatic periods of weeks or months. |
2021-10-23 |
2023-08-13 |
Not clear |
| Aleksi Mikael Markunpoika Hupl. Medical Cannabis for Adult Attention Deficit Hyperactivity Disorder: Sociological Patient Case Report of Cannabinoid Therapeutics in Finland. Medical cannabis and cannabinoids. vol 1. issue 2. 2021-10-23. PMID:34676327. |
medical cannabis for adult attention deficit hyperactivity disorder: sociological patient case report of cannabinoid therapeutics in finland. |
2021-10-23 |
2023-08-13 |
Not clear |
| Paul T Kocis, Kent E Vran. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical cannabis and cannabinoids. vol 3. issue 1. 2021-10-23. PMID:34676340. |
in the case of medical cannabis and medicinal cannabinoids, this is further complicated by the fact that the increased therapeutic use of marijuana extracts and cannabidiol oil will not have regulatory agency approved pi. |
2021-10-23 |
2023-08-13 |
Not clear |
| Paul T Kocis, Kent E Vran. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Medical cannabis and cannabinoids. vol 3. issue 1. 2021-10-23. PMID:34676340. |
in addition to a comprehensive list of drug-drug interactions, we also provide a list of 57 prescription medications displaying a narrow therapeutic index that are potentially impacted by concomitant cannabinoid use (whether through prescription use of cannabinoid medications or therapeutic/recreational use of cannabis and its extracts). |
2021-10-23 |
2023-08-13 |
Not clear |